Literature DB >> 19576371

A customized standard to assess fetal growth in a US population.

Jason Gardosi1, Andre Francis.   

Abstract

OBJECTIVE: The objective of the study was to assess the factors that affect fetal growth and birthweight, and to derive coefficients for a customized growth chart applicable in an American population. STUDY
DESIGN: This was a prospective cohort study of 35,235 pregnancies. Coefficients for physiological and pathological variables were derived by backward multiple regression.
RESULTS: The expected birthweight at 40.0 weeks for a standard-size primiparous mother of European origin in an uncomplicated pregnancy was 3453.4 g, very similar to the standardized birthweight observed in other populations. Physiological coefficients were derived for maternal height, weight, parity, ethnic origin, and sex of the baby. Smoking, history of preterm delivery, and hypertensive diseases in the current pregnancy all had negative effects on birthweight, whereas babies of diabetic mothers weighed more. Low as well as high body mass index was associated with birthweight deficit at term.
CONCLUSION: Coefficients that allow determination of the customized growth potential, individually adjusted and excluding known pathological factors, have been derived. Babies of obese mothers have an increased risk of not reaching their fetal growth potential.

Entities:  

Mesh:

Year:  2009        PMID: 19576371     DOI: 10.1016/j.ajog.2009.04.035

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

1.  Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth Studies.

Authors:  Julio Mateus; Roger B Newman; Cuilin Zhang; Sarah J Pugh; Jagteshwar Grewal; Sungduk Kim; William A Grobman; John Owen; Anthony C Sciscione; Ronald J Wapner; Daniel Skupski; Edward Chien; Deborah A Wing; Angela C Ranzini; Michael P Nageotte; Nicole Gerlanc; Paul S Albert; Katherine L Grantz
Journal:  Am J Obstet Gynecol       Date:  2019-06-19       Impact factor: 8.661

2.  Snoring during pregnancy and delivery outcomes: a cohort study.

Authors:  Louise M O'Brien; Alexandra S Bullough; Jocelynn T Owusu; Kimberley A Tremblay; Cynthia A Brincat; Mark C Chames; John D Kalbfleisch; Ronald D Chervin
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

3.  A new customized fetal growth standard for African American women: the PRB/NICHD Detroit study.

Authors:  Adi L Tarca; Roberto Romero; Dereje W Gudicha; Offer Erez; Edgar Hernandez-Andrade; Lami Yeo; Gaurav Bhatti; Percy Pacora; Eli Maymon; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2018-02       Impact factor: 8.661

4.  Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial.

Authors:  Xia Sun; Zhendong Zhang; Hui Ning; Hong Sun; Xianghong Ji
Journal:  Metab Brain Dis       Date:  2017-02-17       Impact factor: 3.584

5.  Fetal overgrowth in pregnancies complicated by diabetes: validation of a predictive index in an external cohort.

Authors:  Tracy M Tomlinson; Alexandra M Johnson; Alexandra M Edwards; Gilad A Gross; Dorothea J Mostello
Journal:  Arch Gynecol Obstet       Date:  2020-09-08       Impact factor: 2.344

6.  Customized versus population approach for evaluation of fetal overgrowth.

Authors:  Maged M Costantine; Lisa Mele; Mark B Landon; Catherine Y Spong; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Steve N Caritis; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa; Garland D Anderson
Journal:  Am J Perinatol       Date:  2012-11-12       Impact factor: 1.862

7.  Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women.

Authors:  Carlos A Carreno; Rebecca G Clifton; John C Hauth; Leslie Myatt; James M Roberts; Catherine Y Spong; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Anthony Sciscione; Jorge E Tolosa; George R Saade; Yoram Sorokin
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

8.  The obstetric and neonatal implications of a low value on the 50-g glucose screening test.

Authors:  Kimberly K Ma; Lisa Mele; Mark B Landon; Catherine Y Spong; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Steve N Caritis; Yoram Sorokin; Alan M Peaceman
Journal:  Am J Perinatol       Date:  2012-12-27       Impact factor: 1.862

9.  Population versus customized fetal growth norms and adverse outcomes in an intrapartum cohort.

Authors:  Maged M Costantine; Yinglei Lai; Steven L Bloom; Catherine Y Spong; Michael W Varner; Dwight J Rouse; Susan M Ramin; Steve N Caritis; Alan M Peaceman; Yoram Sorokin; Anthony Sciscione; Brian M Mercer; John M Thorp; Fergal D Malone; Margaret Harper; Jay D Iams
Journal:  Am J Perinatol       Date:  2012-08-14       Impact factor: 1.862

10.  Comparison of methods for identifying small-for-gestational-age infants at risk of perinatal mortality among obese mothers: a hospital-based cohort study.

Authors:  S N Hinkle; L A Sjaarda; P S Albert; P Mendola; K L Grantz
Journal:  BJOG       Date:  2016-02-08       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.